Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: APOPTOSIS ; CANCER ; CELLS ; EXPRESSION ; tumor ; CELL ; INHIBITION ; COMMON ; DIAGNOSIS ; NEW-YORK ; GENE ; GENES ; GENOME ; HYBRIDIZATION ; microarray ; transcription ; DRUG ; METABOLISM ; cell line ; TUMORS ; validation ; LINES ; COMPLEX ; COMPLEXES ; CELL-LINES ; chromosome ; FORM ; DELETION ; IDENTIFICATION ; IN-SITU ; PROGRESSION ; AMPLIFICATION ; COMPARATIVE GENOMIC HYBRIDIZATION ; ARRAYS ; NUMBER ; genetics ; cervical cancer ; CERVICAL-CANCER ; CELL-LINE ; LINE ; DELETIONS ; PATHOGENESIS ; PCR ; REGION ; REGIONS ; ONCOGENE ; RT-PCR ; immune response ; IMMUNE-RESPONSE ; UTERINE CERVIX ; RECURRENT ; FLUORESCENCE ; MICROARRAY ANALYSIS ; fluorescence in situ hybridization ; cell lines ; heredity ; HIGH-LEVEL ; CDNA MICROARRAY ; in situ hybridization ; molecular ; ONCOLOGY ; ARRAY ; LEVEL ; analysis ; PROFILES ; DYSPLASIA ; EXPRESSION PROFILES ; USA ; CANDIDATE ; genomic ; DRUG-METABOLISM ; CDNA-MICROARRAY ; EPHB2 ; 19Q13.3 ; COMPARATIVE-GENOMIC-HYBRIDIZATION ; INVASIVE-CARCINOMA ; MUC4 EXPRESSION
    Abstract: Cervical cancer (CC) cells exhibit complex karyotypic alterations, which is consistent with deregulation of numerous critical genes in its formation and progression. To characterize this karyotypic complexity at the molecular level, we used cDNA array comparative genomic hybridization (aCGH) to analyze 29 CC cases and identified a number of over represented and deleted genes. The aCGH analysis revealed at least 17 recurrent amplicons and six common regions of deletions. These regions contain several known tumor-associated genes, such as those involved in transcription, apoptosis, cytoskeletal remodeling, ion-transport, drug metabolism, and immune response. Using the fluorescence in situ hybridization (FISH) approach we demonstrated the presence of high-level amplifications at the 8q24.3, 11q22.2, and 20q13 regions in CC cell lines. To identify amplification-associated genes that correspond to focal amplicons, we examined one or more genes in each of the 17 amplicons by Affymetrix UI33A expression arrays and serniquantitative reverse-transcription PCR (RT-PCR) in 31 CC tumors. This analysis exhibited frequent and robust upregulated expression in CC relative to normal cervix for genes EPHB2 (1p36), CDCA8 (1p34.3), AIM2 (1q22-23), RFC4, MUC4, and HRASLS (3q27-29), SKP2 (5p12-13), CENTD3 (Sq31.3), PTK2, RECQL4 (8q24), MMP1 and MMP13 (11q22.2), AKT1 (14q32.3), ABCC3 (17q21-22), SMARCA4 (19p13.3) LIG1 (19q13.3), UBE2C (20q13.1), SMCIL1 (Xp11), KIRA (Xq12), TMSN8 (Xq22), and CSAG2 (Xq28). Thus, the gene dosage and expression profiles generated here have enabled the identification of focal amplicons characteristic for the CC genome and facilitated the validation of relevant genes in these amplicons. These data, thus, form an important step toward the identification of biologically relevant genes in CC pathogenesis. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/ 10452257/suppmat. (c) 2007 Wiley-Liss, Inc
    Type of Publication: Journal article published
    PubMed ID: 17243165
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...